ELOHIMED Trademark

Trademark Overview


On Tuesday, October 30, 2018, a trademark application was filed for ELOHIMED with the United States Patent and Trademark Office. The USPTO has given the ELOHIMED trademark a serial number of 79255291. The federal status of this trademark filing is REGISTERED as of Tuesday, March 17, 2020. The ELOHIMED trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of metabolic syndrome disorders, infectious diseases, and complications associated therewith; pharmaceutical products for the prevention and/or treatment of cancer and metastases; pharmaceutical products for use in the prevention and/or treatment of infection, especially HIV; pharmaceutical products for the treatment of bacterial, fungal or viral diseases; pharmaceutical products for the treatment of liver diseases; pharmaceutical products for the treatment and/or prevention of inflammatory, cardiovascular and neurodegenerative diseases; dietetic substances adapted for medical use, namely, capsules, pills, infusions, and tinctures for metabolic syndrome diseases, cancer, bacterial, fungal or viral diseases, particularly HIV; Herbal teas for medicinal purposes

Retail store services and wholesale store services for pharmaceutical products; business advice services, namely, commercial information for consumers; distribution of goods, namely, distribution of pharmaceutical products for advertising purposes; all the aforesaid services relating to pharmaceutical products and medicines

Research and development in the scientific, medical and industrial fields, namely, pharmaceutical industrial fields; research and development of new pharmaceutical products; laboratory research relating to pharmaceuticals; laboratory research services in the field of gene expression, namely, in the field of cancer; laboratory research in the field of bacteriology, fungal or viral disease; clinical research, namely, conducting clinical trials for others; clinical research in the field of oncology; research and development of new products for others in the pharmaceutical and medical field; scientific research for medical purposes; research and development in the field of vaccines; providing scientific research information in the field of pharmaceutical, medical, health and well-being products through on-line computer networks, for customers
elohimed

General Information


Serial Number79255291
Word MarkELOHIMED
Filing DateTuesday, October 30, 2018
Status700 - REGISTERED
Status DateTuesday, March 17, 2020
Registration Number6010165
Registration DateTuesday, March 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of metabolic syndrome disorders, infectious diseases, and complications associated therewith; pharmaceutical products for the prevention and/or treatment of cancer and metastases; pharmaceutical products for use in the prevention and/or treatment of infection, especially HIV; pharmaceutical products for the treatment of bacterial, fungal or viral diseases; pharmaceutical products for the treatment of liver diseases; pharmaceutical products for the treatment and/or prevention of inflammatory, cardiovascular and neurodegenerative diseases; dietetic substances adapted for medical use, namely, capsules, pills, infusions, and tinctures for metabolic syndrome diseases, cancer, bacterial, fungal or viral diseases, particularly HIV; Herbal teas for medicinal purposes
Goods and ServicesRetail store services and wholesale store services for pharmaceutical products; business advice services, namely, commercial information for consumers; distribution of goods, namely, distribution of pharmaceutical products for advertising purposes; all the aforesaid services relating to pharmaceutical products and medicines
Goods and ServicesResearch and development in the scientific, medical and industrial fields, namely, pharmaceutical industrial fields; research and development of new pharmaceutical products; laboratory research relating to pharmaceuticals; laboratory research services in the field of gene expression, namely, in the field of cancer; laboratory research in the field of bacteriology, fungal or viral disease; clinical research, namely, conducting clinical trials for others; clinical research in the field of oncology; research and development of new products for others in the pharmaceutical and medical field; scientific research for medical purposes; research and development in the field of vaccines; providing scientific research information in the field of pharmaceutical, medical, health and well-being products through on-line computer networks, for customers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, April 1, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 1, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressFR

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressFR

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressFR

Trademark Events


Event DateEvent Description
Friday, July 17, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 30, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 30, 2020FINAL DISPOSITION PROCESSED
Wednesday, June 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 17, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, January 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 4, 2020NOTIFICATION PROCESSED BY IB
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 21, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, November 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 21, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, November 21, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 20, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, November 20, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 20, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, November 20, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, November 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 18, 2019REFUSAL PROCESSED BY IB
Wednesday, May 1, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 1, 2019REFUSAL PROCESSED BY MPU
Friday, April 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 5, 2019APPLICATION FILING RECEIPT MAILED
Thursday, April 4, 2019NON-FINAL ACTION WRITTEN
Monday, April 1, 2019ASSIGNED TO EXAMINER
Monday, April 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 28, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB